JPMORGAN CHASE & CO

Position in DERM — Journey Medical Corp

CIK 19617 NEW YORK, NY

Position in DERM

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$39,704

-$5,314 QoQ

Shares Held

8,466

+45.0% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 0.838648712497047.ToString("F0")% Shared 0.ToString("F0")% None 99.16135128750295.ToString("F0")%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $2,053,486,049 across 61 Drug Manufacturers - Specialty & Generic names. DERM ranks #45 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	5,442,067	$716,937,900
2	ZTS	Zoetis Inc.	3,387,174	$400,397,831
3	TEVA	Teva Pharmaceutical Industries Ltd	6,762,744	$203,693,847
4	ALKS	Alkermes plc.	4,101,789	$145,039,257
5	HIMS	Hims & Hers Health, Inc.	5,240,816	$108,799,337
6	HLN	Haleon plc	8,279,468	$82,877,469
7	VTRS	Viatris Inc	5,731,565	$77,433,437
8	RDY	Dr Reddys Laboratories Ltd	4,371,378	$60,543,580

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$39,704	8,466	+45.0%	Shares	Defined	2026-05-13
2025-12-31	$45,018	5,839	+18.2%	Shares	Defined	2026-02-11
2025-09-30	$35,165	4,939	-13.9%	Shares	Defined	2025-11-26
2025-06-30	$41,184	5,736	+1123.0%	Shares	Defined	2025-08-12
2024-09-30	$2,649	469	+2245.0%	Shares	Defined	2024-12-26
2024-06-30	$112	20	+33.3%	Shares	Defined	2024-12-26
2024-03-31	$55	15	-86.6%	Shares	Defined	2024-12-26
2023-12-31	$645	112	+1500.0%	Shares	Defined	2024-12-26
2023-09-30	$19	7	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.